RESUMO
The present study outlines the clinical impact and risk factors of oral mucositis in 79 patients with multiple myeloma following high-dose melphalan for autologous transplant. All patients underwent daily prophylactic low-level indium gallium aluminum phosphate diode laser therapy (660 nm, 15 mW, 3.75 J/cm2, 10 s per point) from the beginning of the conditioning regimen up to day +2. Oral mucositis assessments were made daily until hospital discharge. For analysis, oral mucositis was divided into two groups according to severity: group 1, patients with oral mucositis grade Assuntos
Terapia com Luz de Baixa Intensidade/efeitos adversos
, Melfalan/efeitos adversos
, Mieloma Múltiplo/tratamento farmacológico
, Estomatite/induzido quimicamente
, Estomatite/tratamento farmacológico
, Adulto
, Idoso
, Relação Dose-Resposta a Droga
, Feminino
, Transplante de Células-Tronco Hematopoéticas
, Humanos
, Modelos Logísticos
, Masculino
, Pessoa de Meia-Idade
, Fatores de Risco
, Condicionamento Pré-Transplante/efeitos adversos
, Transplante Autólogo
, Resultado do Tratamento